Onestream Inc(OS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

OS Onestream Inc

Market Closed 11-08 16:00:00 EST

32.34

-1.09

-3.26%

盘后32.34

+0.000.00%

17:37 EST

High33.04	Low29.60	Vol1.69M
Open30.48	D1 Closing33.43	Amplitude10.29%
Mkt Cap5.18B	Tradable Cap905.84M	Total Shares160.31M
T/O53.90M	T/O Rate6.02%	Tradable Shares28.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"OS","market":"US","secType":"STK","nameCN":"Onestream Inc","latestPrice":32.34,"timestamp":1731099600000,"preClose":33.43,"halted":0,"volume":1687416,"hourTrading":{"tag":"盘后","latestPrice":32.34,"preClose":32.34,"latestTime":"17:37 EST","volume":384,"amount":12424.33,"timestamp":1731105426583},"delay":0,"floatShares":28009768,"shares":160305620,"eps":-0.041008,"marketStatus":"Market Closed","change":-1.09,"latestTime":"11-08 16:00:00 EST","open":30.48,"high":33.04,"low":29.6,"amount":53900629.06394,"amplitude":0.102902,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.041008,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1731315600000},"marketStatusCode":7,"adr":0,"listingDate":1721793600000,"exchange":"NASDAQ","adjPreClose":33.43,"preHourTrading":{"tag":"盘前","latestPrice":30.45,"preClose":33.43,"latestTime":"09:29 EST","volume":1792,"amount":56780.598784,"timestamp":1731076199999},"postHourTrading":{"tag":"盘后","latestPrice":32.34,"preClose":32.34,"latestTime":"17:37 EST","volume":384,"amount":12424.33,"timestamp":1731105426583},"volumeRatio":2.214016364683663,"impliedVol":0.3984,"impliedVolPercentile":0.2329},"requestUrl":"/m/hq/s/OS","defaultTab":"news","newsList":[{"id":"2482451317","title":"OneStream Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2482451317","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482451317?lang=en_us&edition=fundamental","pubTime":"2024-11-09 05:47","pubTimestamp":1731102443,"startTime":"0","endTime":"0","summary":"* OneStream Inc    reported quarterly adjusted earnings of 55 cents per share for the quarter ended September 30.  The mean expectation of fourteen analysts for the quarter was for breakeven results p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"OneStream Inc reports results for the quarter ended September 30 - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS"],"gpt_icon":0},{"id":"2482436461","title":"Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2482436461","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482436461?lang=en_us&edition=fundamental","pubTime":"2024-11-09 02:30","pubTimestamp":1731090600,"startTime":"0","endTime":"0","summary":"Objective response rate (ORR) of 46%, 12-month overall survival (OS) of 91.3% and a median overall survival (mOS) of 21.8 months in first line (1L) HPV+ R/M HNSCC patients treated with CUE-101 and KEY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/08/2977826/0/en/Cue-Biopharma-Presents-Positive-Updated-Data-from-its-Phase-1-Trials-of-CUE-101-and-CUE-102-in-Head-and-Neck-Cancer-and-WT1-Positive-Cancers-at-the-SITC-39th-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01308","BK1541","BK1103","CPS","OS","IE00BYQNZ168.SGD","BK4139","IE00BYTNYN87.SGD","SG9999011746.SGD","BK4161","BK4097","CR","BK4213","IE00B12V2V27.USD","PR","CUE","BK4124"],"gpt_icon":0},{"id":"2482548901","title":"OneStream price target raised to $37 from $34 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2482548901","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482548901?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:15","pubTimestamp":1731082518,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on OneStream (OS) to $37 from $34 and keeps an Overweight rating on the shares. Piper raised its price...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/onestream-price-target-raised-to-37-from-34-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/onestream-price-target-raised-to-37-from-34-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2481839484","title":"OneStream price target raised to $35 from $34 at Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2481839484","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481839484?lang=en_us&edition=fundamental","pubTime":"2024-11-08 23:40","pubTimestamp":1731080420,"startTime":"0","endTime":"0","summary":"Scotiabank raised the firm’s price target on OneStream (OS) to $35 from $34 and keeps an Outperform rating on the shares. Despite a challenging yea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/onestream-price-target-raised-to-35-from-34-at-scotiabank?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/onestream-price-target-raised-to-35-from-34-at-scotiabank?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2481101100","title":"OneStream Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101100","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481101100?lang=en_us&edition=fundamental","pubTime":"2024-11-08 22:43","pubTimestamp":1731076980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 08, 2024 09:43 ET (14:43 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS"],"gpt_icon":0},{"id":"2481102312","title":"OneStream reports Q3 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102312","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481102312?lang=en_us&edition=fundamental","pubTime":"2024-11-08 22:29","pubTimestamp":1731076191,"startTime":"0","endTime":"0","summary":"OneStream, Inc. press release : Q3 Non-GAAP operating income was $5.5 million. Revenue of $129.14M   beats by $5.03M.  OneStream is providing the following guidance for the fourth quarter of 2024 and the full year 2024:     Q4'24   FY24   Total Revenue $127M - $129M   $484M - $486M   Non-GAAP Operating Margin 0% - 2%   % - %   Non-GAAP Net Income per Share $0.01 - $0.03   $0.06 - $0.08   Equity-Based Compensation $50M - $55M   $315M - $320M","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4266107-onestream-reports-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2481171790","title":"Analysts’ Opinions Are Mixed on These Technology Stocks: GoPro (GPRO), RingCentral (RNG) and Onestream, Inc. Class A (OS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481171790","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481171790?lang=en_us&edition=fundamental","pubTime":"2024-11-08 20:30","pubTimestamp":1731069045,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Technology sector with new ratings on GoPro (GPRO – Research Report), RingCentral (RNG – Research Repor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-technology-stocks-gopro-gpro-ringcentral-rng-and-onestream-inc-class-a-os?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-technology-stocks-gopro-gpro-ringcentral-rng-and-onestream-inc-class-a-os?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","OS","BK4528","BK4585","BK4078","BK4023","RNG","GPRO"],"gpt_icon":0},{"id":"2481787611","title":"Strong Q3 Results and SaaS Growth Drive Buy Rating for Onestream, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2481787611","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481787611?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:27","pubTimestamp":1731065241,"startTime":"0","endTime":"0","summary":"Koji Ikeda, an analyst from Bank of America Securities, reiterated the Buy rating on Onestream, Inc. Class A (OS – Research Report). The associated...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/strong-q3-results-and-saas-growth-drive-buy-rating-for-onestream-inc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/strong-q3-results-and-saas-growth-drive-buy-rating-for-onestream-inc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OS"],"gpt_icon":0},{"id":"2481807127","title":"Onestream Inc : Piper Sandler Raises Target Price to $37 From $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2481807127","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481807127?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:02","pubTimestamp":1731063755,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nFWN3MF16M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2481009111","title":"Onestream Inc : Raymond James Raises Target Price to $35 From $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2481009111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481009111?lang=en_us&edition=fundamental","pubTime":"2024-11-08 14:31","pubTimestamp":1731047506,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nFWN3ME2A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2481658821","title":"Onestream Q3 Non-GAAP Operating Income Declines, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2481658821","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481658821?lang=en_us&edition=fundamental","pubTime":"2024-11-08 07:04","pubTimestamp":1731020674,"startTime":"0","endTime":"0","summary":"Onestream  reported a Q3 non-GAAP operating income late Thursday of $5.5 million, compared with $8.4 million a year earlier.Revenue in the quarter ended Sept. 30 was $129.1 million, up from $107 million a year earlier.Analysts surveyed by Capital IQ expected $124.1 million.In Q4, the company expects non-GAAP earnings per share of $0.01 to $0.03 on revenue of $127 million to $129 million. Analysts expect normalized EPS of $0.01 and $126.7 million in revenue.For full-year 2024, Onestream now expects non-GAAP EPS of $0.06 to $0.08 on revenue of $484 million to $486 million. It previously projected a non-GAAP range of a loss of $0.05 a share to a profit of $0.01 on revenue of $476 million to $480 million. Analysts are looking for normalized loss per share of $0.02 and $478.6 million in revenue.Price: 29.79, Change: -3.64, Percent Change: -10.89","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OS"],"gpt_icon":0},{"id":"2481152489","title":"OneStream Q3 Adj $(1.06), Same YoY, Sales $129.14M Beat $124.18M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481152489","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481152489?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:18","pubTimestamp":1731014284,"startTime":"0","endTime":"0","summary":"OneStream (NASDAQ:OS) reported quarterly losses of $(1.06) per share. This is unchanged from the same period last year.  The company reported quarterly sales of $129.14 million which beat the analyst consensus estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41824525/onestream-q3-adj-1-06-same-yoy-sales-129-14m-beat-124-18m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"OneStream Q3 Adj $(1.06), Same YoY, Sales $129.14M Beat $124.18M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS"],"gpt_icon":0},{"id":"2481815030","title":"Onestream Inc Outlook Q4 Non-Gaap Net Income per Share $0.01 - $0.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2481815030","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481815030?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:05","pubTimestamp":1731013515,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA5BLH8C:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2481150559","title":"Onestream Inc Qtrly Net Loss per Share of Class a and Class D Common Stock-Basic and Diluted $1.06","url":"https://stock-news.laohu8.com/highlight/detail?id=2481150559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481150559?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:05","pubTimestamp":1731013515,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA5BLH8C:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2481151021","title":"BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2481151021","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481151021?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:01","pubTimestamp":1731013260,"startTime":"0","endTime":"0","summary":"Ozuriftamab vedotin (CAB-ROR2-ADC) Phase 2 trial in squamous cell carcinoma of the head and neck (SCCHN) continues to demonstrate durable clinical responses and median overall survival (OS) of approxi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/07/2977090/0/en/BioAtla-Reports-Third-Quarter-2024-Financial-Results-and-Highlights-Recent-Progress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","LU2065732104.USD","BK4563","BK4552","IE00B12V2V27.USD","TME","IE00BYQNZ168.SGD","BK4108","BK4161","BK4535","IE00BYTNYN87.SGD","LU2039709279.SGD","CR","BK4097","SG9999011746.SGD","BK4548","CAB","BK4565","BK4526","PRGS","LU1023057109.AUD","BK4571","01698","BK4509","BCAB","LU0359201612.USD","LU0359202008.SGD","PR","BK4531","OS","BK4139"],"gpt_icon":1},{"id":"2481516747","title":"Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2481516747","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481516747?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:00","pubTimestamp":1731013200,"startTime":"0","endTime":"0","summary":"-- Recently released ASH abstracts for the company’s Phase 1 and iMMagine-1 studies investigating anito-cel in relapsed or refractory multiple myeloma patients continue to demonstrate durability and a manageable safety profile --. -- 30.2-month median progression-free survival with a median follow-up of 38.1 months in the Phase 1 study of anito-cel; median overall survival not reached --. -- Preliminary results from 58 patients enrolled in the Phase 2 pivotal iMMagine-1 study demonstrated 95% ORR and 62% CR/sCR at a median follow-up of 10.3 months; additional patients with a more recent data cut will be presented during an oral presentation --. -- No delayed neurotoxicities have been observed to date with anito-cel, including no parkinsonism, no cranial nerve palsies, and no Guillain-Barré syndrome across the Phase 1 and iMMagine-1 studies in the more than 140 patients dosed --. REDWOOD CITY, Calif., November 07, 2024----Arcellx, Inc. , a biotechnology company reimagining cell therapy ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0l84ETnjPKqf0BEmALYd5w--~B/aD0xMjMzO3c9NDI0NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/7ebcdd2e484dd54d7e41df3e03850280","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0l84ETnjPKqf0BEmALYd5w--~B/aD0xMjMzO3c9NDI0NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/7ebcdd2e484dd54d7e41df3e03850280"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arcellx-provides-third-quarter-2024-210000121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZL793.SGD","CRS","BK4211","PFS","BK4213","WRD","BK4195","IE00B19Z4B17.USD","BK4006","BK4139","PR","IE00B66KJ199.SGD","IE0031619046.USD","OS","ACLX","BK4097"],"gpt_icon":0},{"id":"2481181068","title":"IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2481181068","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481181068?lang=en_us&edition=fundamental","pubTime":"2024-11-07 23:00","pubTimestamp":1730991600,"startTime":"0","endTime":"0","summary":"IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free survival versus standard-of-care alone Treatment was g","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/07/2976849/0/en/IMUNON-Presents-Positive-Data-from-Phase-2-OVATION-2-Clinical-Trial-of-IMNN-001-in-Advanced-Ovarian-Cancer-at-SITC-39th-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B12V2V27.USD","AEIS","SG9999011746.SGD","01308","IMNN","BK1103","BK4211","BK4195","BK4157","BK1541","IE00BYTNYN87.SGD","PFS","BK4139","SITC","IE00B7SZL793.SGD","IE00B66KJ199.SGD","IE00BYQNZ168.SGD","BK4231","WRD","BK4080","BK4097","OS","IE0031619046.USD","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2481903507","title":"Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2481903507","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481903507?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980800,"startTime":"0","endTime":"0","summary":"Achieved $28.2 million in RYTELO  net product revenue in first full quarter of sales. Received $250 million in gross proceeds from synthetic royalty and debt financings with Royalty Pharma and Pharmakon Advisors, with access to an additional $125 million in debt. FOSTER CITY, Calif., November 07, 2024----Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today reported financial results for the third quarter of 2024 and recent business highlights.Strong execution in the first full quarter of U.S. launch, with net product revenue for RYTELO  of $28.2 million in the third quarter of 2024.New data to be presented at upcoming American Society for Hematology  Annua","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/zZLo_DXqApn6_1miYjGswg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/42a99b4bc39a17084482402aa4c47f6e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/zZLo_DXqApn6_1miYjGswg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/42a99b4bc39a17084482402aa4c47f6e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/geron-corporation-reports-third-quarter-120000278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4113","ASH","BK4087","BK4526","CHMP","GERN","BK4109","BK4563","BK4585","LU2463526074.USD","MF","OS","BK4097","BK4588","BK4539","MAA","BK4215","BK4139"],"gpt_icon":0},{"id":"2481951523","title":"Xencor Reports Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481951523","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481951523?lang=en_us&edition=fundamental","pubTime":"2024-11-07 05:01","pubTimestamp":1730926860,"startTime":"0","endTime":"0","summary":"PASADENA, Calif., November 06, 2024----Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today reported financial results for the third quarter ended September 30, 2024 and provided a review of recent business and clinical-stage program updates.\"In September, we provided updates across our clinical pipeline of XmAb bispecific T-cell engagers in oncology and introduced our new autoimmune programs, including the B-cell depleting bispecific antibodies plamotamab and XmAb657, and XmAb942, our high potency anti-TL1A antibody with extended half-life in development for patients with inflammatory bowel disease. This week, we announced that XmAb942 advanced into a Phase 1 dose-escalation study in healthy volunteers,\" said Bassil Dahiyat, Ph.D., president and chief executive officer at Xencor. \"We have been rebalancing our broad portfolio to focus on programs that leverage our protein engineering str","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0MSG1elMy9yJBLZxf4553g--~B/aD0yNzA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6d6be7ce42a450e64666d5e26292ab07","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0MSG1elMy9yJBLZxf4553g--~B/aD0yNzA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6d6be7ce42a450e64666d5e26292ab07"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/xencor-reports-third-quarter-2024-210100156.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["XNCR","OS","BK4217","BK4097","IBD","BK4588","BK4084","BK4585","BK4139","PSA","BK4533"],"gpt_icon":0},{"id":"2481987918","title":"4 Broadcast Radio & TV Stocks to Watch From a Challenging Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2481987918","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481987918?lang=en_us&edition=fundamental","pubTime":"2024-11-06 23:02","pubTimestamp":1730905320,"startTime":"0","endTime":"0","summary":"The Zacks Broadcast Radio and Television industry has been grappling with an escalation in cord-cutting despite a surge in demand for streaming content. However, industry players such as Netflix NFLX, Fox FOXA, Roku ROKU and TEGNA TGNA are reaping the benefits of a massive spike in digital content consumption. These companies are thriving due to their diverse content offerings, which include original, regional, and short-form content tailored for small screens like smartphones and tablets. Improved Internet speed and penetration, coupled with technological advancements, have been advantageous for industry participants. As monetization and revenues from advertising spending continue to be modest, strategies focused on profit protection, cash management and greater technology integration have gained significance and are expected to aid these companies in driving top-line growth in the near term.4 Broadcast Radio and Television Industry Trends to Watch","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/rVqNeT7UeWLce_x1ash.ng--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/be4ff6ebea80920398b108572da9ed1e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/rVqNeT7UeWLce_x1ash.ng--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/be4ff6ebea80920398b108572da9ed1e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/4-broadcast-radio-tv-stocks-150200777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FOXA","BK4581","LU1064131342.USD","ESmain","SDS","BK4534","LU2237957902.USD","DIS","LU0082616367.USD","LU1069344957.HKD","BK4125","IE00BQXX3F31.USD","LU0868494617.USD","IE00BQXX3D17.EUR","SPXU","SH","LU1861559042.SGD","BK4550","TGNA","OS","LU1435385759.SGD","BK4527","BK4559","SGXZ23171101.USD","BK4100","LU0868494708.USD","TTM","LU1720051017.SGD","SPY","LU1861558580.USD","IVV","BK4551","BK4585","LU1429558221.USD","NFLX",".SPX","TV","VOO","LU0942090050.USD","ROKU","OEX","UPRO","BK4588","SSO","LU0719512351.SGD","OEF","IE00BKPKM429.USD","BK4108","LU1988902786.USD","BK4548"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.onestream.com","stockEarnings":[{"period":"1week","weight":0.0791},{"period":"1month","weight":0.1102},{"period":"3month","weight":0.1824},{"period":"6month","weight":0.617},{"period":"ytd","weight":0.617}],"compareEarnings":[{"period":"1week","weight":0.0475},{"period":"1month","weight":0.0365},{"period":"3month","weight":0.1223},{"period":"6month","weight":0.1485},{"period":"1year","weight":0.3788},{"period":"ytd","weight":0.2585}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Onestream Inc","nameEN":"Onestream Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Onestream Inc(OS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Onestream Inc(OS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Onestream Inc,OS,Onestream Inc股票,Onestream Inc股票老虎,Onestream Inc股票老虎国际,Onestream Inc行情,Onestream Inc股票行情,Onestream Inc股价,Onestream Inc股市,Onestream Inc股票价格,Onestream Inc股票交易,Onestream Inc股票购买,Onestream Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Onestream Inc(OS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Onestream Inc(OS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}